Ole Andreas Halvorsen Net Worth - Insider Trades and Bio as of Jul 9, 2026

BBIOBridgeBio Pharma, Inc.SEC CIK: 0001133006

Estimated Net Worth

$4.36 Billion0.0%vs Last Year

Last Updated: May 19, 2026 11:08 PM EST

Transaction Summary

Total Transactions117

Buy-Sell Ratio2.36

Buy Transactions52

Sell Transactions22

Transaction Volume

Total Volume-$1.35B

Net Volume$2.69B

Buy Volume$673.53M

Sell Volume-$2.02B

Trade Analysis

AVG Trade Size-$12.72M

Largest Trade$200.00M

Most Active MonthJun

Most Active Year2019

Trading Sentiment

OverallBullish

Recent TradeSelling

Last 90 Days0 Trades

ConvictionNone

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Ole Andreas Halvorsen has an estimated net worth of $4.36 Billion. This is based on reported shares across multiple companies, which include Amylyx Pharmaceuticals, Inc., Adaptive Biotechnologies Corp, Zentalis Pharmaceuticals, Inc., RayzeBio, Inc., Editas Medicine, Inc., Inhibrx, Inc., Arbutus Biopharma Corp, Myovant Sciences Ltd., Roivant Sciences Ltd., PROCEPT BioRobotics Corp, BridgeBio Pharma, Inc., 4D Molecular Therapeutics, Inc., Rallybio Corp, Ginkgo Bioworks Holdings, Inc., APi Group Corp, FIGS, Inc., Urovant Sciences Ltd., Axovant Gene Therapies Ltd., FIRST DATA CORP, Frazier Lifesciences Acquisition Corp, Wayfair Inc., STANDARD BIOTOOLS INC., Inhibrx Biosciences, Inc., and ACUREN CORP.

2019 was Ole Andreas Halvorsen's most active year for acquiring shares with 72 total transactions. Ole Andreas Halvorsen's most active month to acquire stocks was the month of May. 2024 was Ole Andreas Halvorsen's most active year for disposing of shares, totalling 31 transactions. Ole Andreas Halvorsen's most active month to dispose stocks was the month of August. 2024 saw Ole Andreas Halvorsen paying a total of $403,483,197.60 for 16,401,756 shares, this is the most they've acquired in one year. In 2024 Ole Andreas Halvorsen cashed out on 53,525,867 shares for a total of $1,320,200,039.30, their largest year based on trade value.

Holdings & Transactions

BBIObridgebio pharma, inc.

Updated: Jul 01, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.16	3.50M	$44.00	-$154.00M	Jul 01, 2025	18.56M	Sale	—	Jun 27	View
From 4	-0.12	3.07M	$34.90	-$106.99M	Jan 31, 2025	22.06M	Sale	—	Jan 31	View
From 4	-0.06	1.50M	$35.00	-$52.50M	Jul 19, 2023	25.12M	Sale	—	Jul 18	View
From 4	-0.74	75.61M	$17.00	—	Jun 28, 2019	26.62M	Buy-Options	—	Jun 27	View
From 4	-0.74	75.61M	$17.00	—	Jun 28, 2019	26.62M	Buy-Options	—	Jun 27	View
From 3	—	—	—	—	Jun 27, 2019	—	—	—	—	View

INBXinhibrx biosciences, inc.

Updated: Oct 09, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.20	350.00K	$32.25	-$11.29M	Oct 09, 2025	1.44M	Sale	—	Oct 07	View
From 3	—	—	—	—	Jun 07, 2024	1.79M	—	—	—	View

TICacuren corp

Updated: Feb 14, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 3	—	—	—	—	Feb 14, 2025	34.36M	—	—	—	View

RYZBrayzebio, inc.

Updated: Feb 28, 2024VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	6.64M	—	—	Feb 28, 2024	—	Disposition	—	Feb 26	View
From 4	-1.00	6.64M	—	—	Feb 28, 2024	—	Disposition	—	Feb 26	View
From 4	0.28	1.45M	$18.00	—	Sep 21, 2023	6.64M	Purchase	—	Sep 19	View
From 4	0.28	1.45M	$18.00	—	Sep 21, 2023	6.64M	Purchase	—	Sep 19	View
From 3	—	—	—	—	Sep 14, 2023	—	—	—	—	View
From 3	—	—	—	—	Sep 14, 2023	—	—	—	—	View

INBXinhibrx, inc.

Updated: Jun 03, 2024VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	8.19M	$30.00	-$245.69M	Jun 03, 2024	—	Disposition	—	May 30	View
From 4	—	1.55M	$19.35	$30.00M	Aug 30, 2023	8.19M	Purchase	—	Aug 28	View
From 4	0.93	1.33M	$30.00	$40.00M	Oct 12, 2022	6.64M	Purchase	—	Oct 07	View
From 4	0.14	180.22K	$18.92	$3.41M	Aug 28, 2020	5.31M	Purchase	—	Aug 26	View
From 4	0.12	131.47K	$19.39	$2.55M	Aug 25, 2020	5.13M	Purchase	—	Aug 24 - 25	View
From 3	—	—	—	—	Aug 25, 2020	4.99M	—	—	—	View

FDMT4d molecular therapeutics, inc.

Updated: Jan 05, 2024VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.11	540.00K	$19.53	-$10.55M	Jan 05, 2024	4.25M	Sale	—	Jan 04	View
From 4	0.22	850.00K	$16.00	$13.60M	May 11, 2023	4.79M	Purchase	—	May 09	View
From 4	0.39	1.10M	$23.00	—	Dec 17, 2020	3.94M	Purchase	—	Dec 15	View
From 3	—	—	—	—	Dec 10, 2020	—	—	—	—	View

APGapi group corp

Updated: Jun 18, 2024VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	1.95M	$38.15	-$74.46M	Jun 18, 2024	27.03M	Sale	—	Jun 17	View
From 4	-1.00	1.95M	$38.15	-$74.46M	Jun 18, 2024	27.03M	Sale	—	Jun 17	View
From 4	-0.61	3.04M	$34.25	-$104.07M	Mar 07, 2024	28.98M	Sale	—	Mar 05	View
From 4	-0.61	3.04M	$34.25	-$104.07M	Mar 07, 2024	28.98M	Sale	—	Mar 05	View
From 4	0.39	3.94M	$30.75	$51.74M	Mar 01, 2024	41.08M	Options	—	Feb 28	View
From 4	0.39	3.94M	$30.75	$51.74M	Mar 01, 2024	41.08M	Options	—	Feb 28	View
From 4	-0.19	6.50M	$31.30	-$203.45M	Jan 04, 2024	27.89M	Sale	—	Jan 02	View
From 4	-0.19	6.50M	$31.30	-$203.45M	Jan 04, 2024	27.89M	Sale	—	Jan 02	View
From 4	—	200.00K	$1,000.00	$200.00M	Jan 05, 2022	200.00K	Purchase	—	Jan 03	View
From 3	—	—	—	—	Apr 28, 2020	33.33M	—	—	—	View

LABstandard biotools inc.

Updated: Mar 20, 2024VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 3	—	—	—	—	Mar 20, 2024	58.65M	—	—	—	View

ROIVroivant sciences ltd.

Updated: Jun 26, 2023VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.15	13.00M	$9.90	-$128.70M	Jun 26, 2023	75.24M	Sale	—	Jun 22	View
From 4	-0.15	13.00M	$9.90	-$128.70M	Jun 26, 2023	75.24M	Sale	—	Jun 22	View
From 3	—	—	—	—	Oct 01, 2021	88.24M	—	—	—	View
From 3	—	—	—	—	Oct 01, 2021	88.24M	—	—	—	View

AMLXamylyx pharmaceuticals, inc.

Updated: Sep 09, 2022VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.10	1.40M	$29.80	-$41.72M	Sep 09, 2022	12.24M	Sale	—	Sep 08 - 09	View
From 4	0.47	2.30M	$19.00	$43.70M	Jan 13, 2022	7.17M	Purchase	—	Jan 11 - 11	View
From 3	—	—	—	—	Jan 11, 2022	—	—	—	—	View

PRCTprocept biorobotics corp

Updated: Mar 22, 2022VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.25	1.25M	$29.90	-$37.35M	Mar 22, 2022	3.66M	Sale	—	Mar 18	View
From 4	0.09	400.00K	$35.00	$14.00M	Sep 21, 2021	4.91M	Purchase	—	Sep 17	View
From 3	—	—	—	—	Sep 14, 2021	308.14K	—	—	—	View

RLYBrallybio corp

Updated: Nov 17, 2022VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	3.33M	$6.00	$20.00M	Nov 17, 2022	3.33M	Purchase	—	Nov 15	View
From 4	-0.81	17.38M	$13.00	—	Aug 02, 2021	4.19M	Buy-Options	—	Jul 29	View
From 3	—	—	—	—	Jul 29, 2021	—	—	—	—	View

DNAginkgo bioworks holdings, inc.

Updated: Mar 04, 2022VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	—	—	—	Mar 04, 2022	339.06M	Acq/Dis	—	Mar 02	View
From 3	—	—	—	—	Sep 23, 2021	339.06M	—	—	—	View

frazier lifesciences acquisition corp

Updated: Nov 25, 2022

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	3.67M	—	—	Nov 25, 2022	—	Options	—	Nov 22	View
From 4	0.30	847.06K	$10.08	$8.54M	Nov 04, 2022	3.67M	Purchase	—	Nov 02	View
From 3	—	—	—	—	Nov 04, 2022	2.82M	—	—	—	View

FIGSfigs, inc.

Updated: Sep 03, 2021VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.01	200.00K	$46.78	-$9.36M	Sep 03, 2021	14.74M	Sale	—	Sep 02 - 03	View
From 3	—	—	—	—	Jun 07, 2021	14.94M	—	—	—	View

ADPTadaptive biotechnologies corp

Updated: Dec 16, 2020VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.03	1.00M	$55.65	-$55.65M	Dec 16, 2020	29.99M	Sale	—	Dec 14	View
From 4	-0.07	2.50M	$49.52	-$123.79M	Nov 13, 2020	30.99M	Sale	—	Nov 11	View
From 4	-0.07	2.50M	$49.52	-$123.79M	Nov 13, 2020	30.99M	Sale	—	Nov 11	View
From 4	-0.13	4.91M	$24.98	-$122.71M	Jan 30, 2020	33.49M	Sale	—	Jan 28	View
From 4	-0.13	4.91M	$24.98	-$122.71M	Jan 30, 2020	33.49M	Sale	—	Jan 28	View
From 4	0.01	250.00K	$20.00	—	Jul 02, 2019	38.41M	Purchase	—	Jul 01	View
From 4	0.01	250.00K	$20.00	—	Jul 02, 2019	38.41M	Purchase	—	Jul 01	View
From 3	—	—	—	—	Jun 26, 2019	1.43M	—	—	—	View
From 3	—	—	—	—	Jun 26, 2019	1.43M	—	—	—	View

ZNTLzentalis pharmaceuticals, inc.

Updated: Dec 03, 2020VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.11	500.00K	$50.50	-$25.25M	Dec 03, 2020	3.94M	Sale	—	Dec 01	View
From 4	0.19	725.00K	$18.00	$13.05M	Apr 08, 2020	4.44M	Purchase	—	Apr 07	View
From 3	—	—	—	—	Apr 03, 2020	3.72M	—	—	—	View

ABUSarbutus biopharma corp

Updated: Jul 12, 2019VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	—	—	—	Jul 12, 2019	—	—	—	—	View
From 4	—	—	—	—	Jul 12, 2019	—	—	—	—	View
From 4	1.33	664.00K	$100.00	$66.40M	Jan 16, 2018	1.16M	Purchase	—	Jan 12	View
From 4	—	500.00K	$100.00	$50.00M	Oct 17, 2017	500.00K	Purchase	—	Oct 16	View
From 3	—	—	—	—	Jul 13, 2016	16.01M	—	—	—	View

myovant sciences ltd.

Updated: Jul 12, 2019

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	—	—	—	Jul 12, 2019	—	—	—	—	View
From 4	—	—	—	—	Jul 12, 2019	—	—	—	—	View
From 4	0.06	2.42M	$8.25	$20.00M	Jun 13, 2019	40.77M	Purchase	—	Jun 04	View
From 4	0.06	2.42M	$8.25	$20.00M	Jun 13, 2019	40.77M	Purchase	—	Jun 04	View
From 4	0.03	1.11M	$20.27	$22.50M	Apr 05, 2018	38.34M	Purchase	—	Apr 02	View
From 3	—	—	—	—	Oct 26, 2016	37.23M	—	—	—	View

urovant sciences ltd.

Updated: Jul 12, 2019

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	—	—	—	Jul 12, 2019	—	—	—	—	View
From 4	—	—	—	—	Jul 12, 2019	—	—	—	—	View
From 4	0.00	18.20K	$8.32	$151.38K	Jun 19, 2019	22.86M	Purchase	Scheduled	Jun 17 - 19	View
From 4	0.00	18.20K	$8.32	$151.38K	Jun 19, 2019	22.86M	Purchase	Scheduled	Jun 17 - 19	View
From 4	0.00	22.01K	$8.06	$177.30K	Jun 14, 2019	22.84M	Purchase	Scheduled	Jun 12 - 14	View
From 4	0.00	22.01K	$8.06	$177.30K	Jun 14, 2019	22.84M	Purchase	Scheduled	Jun 12 - 14	View
From 4	0.00	21.34K	$8.31	$177.25K	Jun 11, 2019	22.82M	Purchase	Scheduled	Jun 07 - 11	View
From 4	0.00	21.34K	$8.31	$177.25K	Jun 11, 2019	22.82M	Purchase	Scheduled	Jun 07 - 11	View
From 4	0.00	21.12K	$7.86	$165.95K	Jun 06, 2019	22.80M	Purchase	Scheduled	Jun 04 - 06	View
From 4	0.00	21.12K	$7.86	$165.95K	Jun 06, 2019	22.80M	Purchase	Scheduled	Jun 04 - 06	View
From 4	0.00	17.75K	$7.83	$138.95K	Jun 03, 2019	22.78M	Purchase	Scheduled	May 30 - 03	View
From 4	0.00	17.75K	$7.83	$138.95K	Jun 03, 2019	22.78M	Purchase	Scheduled	May 30 - 03	View
From 4	0.00	14.48K	$7.63	$110.46K	May 29, 2019	22.76M	Purchase	Scheduled	May 24 - 29	View
From 4	0.00	14.48K	$7.63	$110.46K	May 29, 2019	22.76M	Purchase	Scheduled	May 24 - 29	View
From 4	0.00	19.83K	$5.61	$87.80K	May 23, 2019	48.41M	Purchase	Scheduled	May 21 - 23	View
From 4	0.00	19.83K	$8.22	$162.92K	May 23, 2019	22.75M	Purchase	Scheduled	May 21 - 23	View
From 4	0.00	21.61K	$7.63	$162.88K	May 20, 2019	31.35M	Purchase	—	May 16 - 20	View
From 4	0.00	21.61K	$7.63	$162.88K	May 20, 2019	31.35M	Purchase	—	May 16 - 20	View
From 4	0.13	2.68M	$14.00	$37.50M	Oct 03, 2018	22.70M	Purchase	—	Oct 01	View
From 3	—	—	—	—	Sep 26, 2018	20.03M	—	—	—	View

SIOXaxovant gene therapies ltd.

Updated: Jul 12, 2019VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	—	—	—	Jul 12, 2019	—	—	—	—	View
From 4	—	—	—	—	Jul 12, 2019	—	—	—	—	View
From 4	0.07	6.67M	$1.50	$10.00M	Mar 19, 2019	105.95M	Purchase	—	Mar 18	View
From 4	0.07	6.67M	$1.50	$10.00M	Mar 19, 2019	105.95M	Purchase	—	Mar 18	View
From 4	0.11	10.00M	$1.00	$10.00M	Dec 20, 2018	99.29M	Purchase	—	Dec 18	View
From 4	0.11	10.00M	$1.00	$10.00M	Dec 20, 2018	99.29M	Purchase	—	Dec 18	View
From 4	0.19	14.29M	$1.75	$25.00M	Jun 07, 2018	89.29M	Purchase	—	Jun 05	View
From 3	—	—	—	—	Jul 13, 2016	75.00M	—	—	—	View

EDITeditas medicine, inc.

Updated: Feb 09, 2016VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4/A	-0.39	3.43M	—	—	Feb 09, 2016	5.46M	Buy-Options	—	Feb 08 - 08	View
From 4	-0.39	3.43M	—	—	Feb 08, 2016	5.46M	Buy-Options	—	Feb 08 - 08	View
From 3	—	—	—	—	Feb 02, 2016	—	—	—	—	View

first data corp

Updated: Apr 15, 2016

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	—	—	—	Apr 15, 2016	43.50M	Options	—	Apr 13	View
From 3	—	—	—	—	Oct 15, 2015	—	—	—	—	View

Wwayfair inc.

Updated: Nov 24, 2014VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.02	35.20K	$22.73	$800.07K	Nov 24, 2014	2.33M	Purchase	—	Nov 20	View
From 4	0.02	45.00K	—	—	Nov 12, 2014	2.30M	Purchase	—	Nov 07	View
From 4	0.00	2.40K	$25.17	$60.41K	Nov 05, 2014	2.25M	Purchase	—	Nov 03	View
From 4	0.19	853.04K	—	—	Oct 08, 2014	5.30M	Purchase	—	Oct 02	View
From 3	—	—	—	—	Oct 08, 2014	—	—	—	—	View

Benzinga

Benzinga

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Holdings & Transactions